ARID1A型
癌症研究
表观遗传学
生物
表观遗传学
染色质
增强子
癌症
溴尿嘧啶
遗传学
DNA甲基化
基因
基因表达
转录因子
突变
作者
Chang Xu,Kie Kyon Huang,Jia Hao Law,Joy Shijia Chua,Taotao Sheng,Natasha Flores,Melissa Pool Pizzi,Atsushi Okabe,Angie Lay Keng Tan,Feng Zhu,Vikrant Kumar,Xiaoyin Lu,Ana Morales Benitez,Benedict Shi Xiang Lian,Haoran Ma,Shamaine Wei Ting Ho,Kalpana Ramnarayanan,Chukwuemeka George Anene-Nzelu,Milad Razavi-Mohseni,Siti Aishah Binte Abdul Ghani
出处
期刊:Gut
[BMJ]
日期:2023-03-14
卷期号:72 (9): 1651-1663
被引量:29
标识
DOI:10.1136/gutjnl-2022-328332
摘要
Our results suggest a therapeutic strategy for ARID1A-mutated GCs targeting both tumour-intrinsic (BRD4-assocatiated promoter activation) and extrinsic (NFKB immunomodulation) cancer phenotypes.
科研通智能强力驱动
Strongly Powered by AbleSci AI